General MedicationsORALStandard
RETROVIR
ZIDOVUDINE
Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview RETROVIR is listed in Drugs@FDA under application 019655 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ZIDOVUDINE Form and strength CAPSULE;ORAL - 100MG Sponsor VIIV HLTHCARE Submission history Latest submission status date: 2024-12-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview RETROVIR is listed in Drugs@FDA under application 019655 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ZIDOVUDINE Form and strength CAPSULE;ORAL - 100MG Sponsor VIIV HLTHCARE Submission history Latest submission status date: 2024-12-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.